Signals in our brain are not always processed in the same way: certain receptors modulate these mechanisms, influencing our mood, perception, and behavior in various ways. One of these is the 5-HT2A ...
InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP-248 for acute myeloid leukaemia: Beijing Friday, September 20, 2024, 18:00 Hrs [IST] InnoCare Pharma ...